Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001437749-23-010826
Filing Date
2023-04-21
Accepted
2023-04-21 16:58:43
Documents
16
Period of Report
2023-01-31
Items
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K/A isr20230420_8ka.htm   iXBRL 8-K/A 26993
2 EXHIBIT 23.1 ex_504096.htm EX-23.1 2718
3 EXHIBIT 99.1 ex_504101.htm EX-99.1 533222
4 EXHIBIT 99.2 ex_504102.htm EX-99.2 437410
  Complete submission text file 0001437749-23-010826.txt   1223947

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA isr-20230131.xsd EX-101.SCH 3593
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE isr-20230131_def.xml EX-101.DEF 12288
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE isr-20230131_lab.xml EX-101.LAB 16481
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE isr-20230131_pre.xml EX-101.PRE 12554
10 EXTRACTED XBRL INSTANCE DOCUMENT isr20230420_8ka_htm.xml XML 2795
Mailing Address 350 HILLS STREET, SUITE 106 RICHLAND WA 99354
Business Address 350 HILLS STREET, SUITE 106 RICHLAND WA 99354 (509) 375-1202
Perspective Therapeutics, Inc. (Filer) CIK: 0000728387 (see all company filings)

EIN.: 411458152 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-33407 | Film No.: 23837051
SIC: 3841 Surgical & Medical Instruments & Apparatus